Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Techniques of therapeutic communication I: Active Listening, Sharing Observations, Validation, and Using Touch01:15

Techniques of therapeutic communication I: Active Listening, Sharing Observations, Validation, and Using Touch

8.2K
The history of therapeutic communication can be traced back to Florence Nightingale, who emphasized the importance of developing trusting relationships with patients. She taught that the presence of nurses with patients results in therapeutic healing.
Therapeutic communication is not the same as social interaction. Social interaction has no goal or purpose and consists of casual information sharing, whereas therapeutic communication has a plan or purpose for the conversation. Therapeutic...
8.2K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

2.3K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.3K
Cancer Therapies02:49

Cancer Therapies

10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathway to terrorist behaviors: The role of childhood experiences, personality traits, and ideological motivations in a sample of Iraqi prisoners.

Journal of forensic sciences·2023
Same author

Distinguishing lone from group actor terrorists: A comparison of attitudes, ideologies, motivations, and risks.

Journal of forensic sciences·2022
Same author

When Is Sadness a Sickness?

Perspectives in biology and medicine·2021
Same author

Informed consent revoked.

Neuromodulation : journal of the International Neuromodulation Society·2011
Same author

The need for a new "new medical model": a bio-psychosocial-spiritual model.

Southern medical journal·2011
Same author

Spirituality and cancer: an introduction.

Southern medical journal·2011

Related Experiment Video

Updated: Mar 1, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

4.0K

How Should Clinicians Respond to Transference Reactions with Cancer Patients?

Fatima Noorani1, Allen R Dyer2

  • 1Clinical assistant professor in the Department of Psychiatry and Behavioral Sciences at the George Washington University in Washington, DC, and the medical director of the McClendon Center.

AMA Journal of Ethics
|May 30, 2017
PubMed
Summary

Understanding transference reactions is crucial for cancer patients. Properly managing these, along with countertransference, strengthens the therapeutic alliance and improves cancer care outcomes.

More Related Videos

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
10:10

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy

Published on: October 18, 2011

13.1K
Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.3K

Related Experiment Videos

Last Updated: Mar 1, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

4.0K
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
10:10

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy

Published on: October 18, 2011

13.1K
Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.3K

Area of Science:

  • Psychology
  • Oncology
  • Psychiatry

Background:

  • Cancer patients experience vulnerability and require specialized support.
  • Transference reactions, if mismanaged, can disrupt the patient-clinician therapeutic alliance.
  • Oncology settings may necessitate protocol modifications for patients in distress.

Purpose of the Study:

  • To highlight the significance of recognizing and managing transference and countertransference in oncology.
  • To examine how transference reactions can lead to treatment termination in cancer patients.
  • To emphasize the role of empathy, integrity, and boundary maintenance in patient care.

Main Methods:

  • Case commentary on a young woman with cancer who terminated treatment due to transference reactions.
  • Discussion of clinical management strategies for transference and countertransference.
  • Exploration of maintaining therapeutic boundaries and responding to patient concerns.

Main Results:

  • Mismanaged transference can negatively impact the patient-clinician relationship and treatment.
  • Effective management of transference and countertransference is vital for therapeutic success.
  • Empathy and integrity are key components in addressing cancer patients' needs.

Conclusions:

  • Clinicians must be attentive to transference and countertransference in cancer care.
  • Managing transference reactions is essential for maintaining the therapeutic alliance and optimizing patient outcomes.
  • Flexible and empathetic clinical responses are crucial for supporting vulnerable cancer patients.